Which companies receive government funding?
Government-backed companies are not a random sample of the startup population. Funding programmes are often designed around specific policy objectives, whether supporting research commercialisation, encouraging regional growth, advancing sustainability goals, or accelerating strategic technologies.
Beauhurst data shows that companies receiving government funding are more likely to operate within digital and technologies. What’s more striking is the geographical split of these companies. Unsurprisingly, the highest percentage are headquartered in London, 17%. But then Scotland comes second with 14%. And when we look at our cohort of 543 companies, the largest share resides in Scotland — 21%. It’s unusual to see any country or region beat the capital.
One explanation may lie in Scotland’s network of public funders and innovation agencies. Compared to many UK regions, Scotland benefits from a particularly active network of government-backed investment vehicles, innovation agencies, and university commercialisation programmes. Organisations such as Scottish Enterprise, the Scottish National Investment Bank, and a number of university-linked funds have played an important role in helping early-stage companies bridge the gap between research and commercialisation.
Scotland also has a disproportionately strong concentration of spinout activity relative to its size, particularly in sectors such as life sciences, energy transition, deeptech, and advanced engineering. These businesses often require significant upfront capital and longer development timelines before generating meaningful revenue, making them natural candidates for government support. As a result, public funding forms a more visible part of the startup financing landscape than it does in regions where businesses are more likely to be bootstrapped or venture-backed from inception.
Do government-backed startups grow faster?
One way to assess the effectiveness of public funding is to examine whether recipients subsequently achieve stronger growth than other startups.
At first glance, the answer appears to be: not necessarily. Among businesses that received government funding in 2025, 9% have already achieved one of Beauhurst’s 10% or 20% scaleup signals. However, as we already highlighted, many publicly funded companies operate in sectors with longer development and commercialisation cycles, meaning the impact of funding often takes years to materialise.
Looking across a longer timeframe provides a clearer picture. Of the 5,116 companies that have received government backing, 17% have achieved Beauhurst’s 10% or 20% scaleup signal at some point in their lifecycle. Among companies that received funding without government support, the equivalent figure is 14%.
The difference is marginal, but perhaps more significant than it first appears. Government funding is frequently directed towards research-intensive businesses in sectors such as deeptech, life sciences, advanced manufacturing, and clean energy. In other words, industries where growth is often slower. Despite these challenges, government-backed businesses achieve scaleup milestones at broadly the same rate as their privately funded counterparts.
The fundraising data tells a more complicated story. On average, companies that received government support raised £3.68m in equity investment, compared with £10.1m among companies that never received public funding, a gap that appears significant. But mean figures are easily skewed by a small number of very large venture rounds, which are far more common among purely private companies.
The median figures are more instructive: government-backed companies raised a median value of £500k, compared with £800k for their privately funded peers. The gap narrows considerably, and what remains is largely explained by capital structure rather than commercial underperformance. Grants and other non-dilutive funding give early-stage businesses the resources to develop products and validate technologies without immediately turning to equity investors, reducing, rather than reflecting, their need for large venture rounds.
Taken together, the data points in the same direction. Government-backed companies help businesses achieve comparable growth outcomes with different funding profiles, particularly in sectors where innovation cycles are longer and commercial risk is higher. Government support functions as patient capital — longer-horizon funding that gives companies the time to develop before they need to satisfy commercial investors — rather than a growth accelerator.